Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Probuphine NDA resubmitted to FDA

Sep. 1, 2015

Regenerative peptide mitigates radiation-induced gastrointestinal damage

Aug. 24, 2015

FDA approves IND for Saniona's NS-2359 in the treatment of cocaine addiction

Aug. 17, 2015

Virginia Commonwealth University patents NO-releasing allosteric Hb modifiers

July 21, 2015

GNI initiates Chinese pilot study of Etuary for radiation-induced pneumonitis

July 8, 2015

NIDA tests AZD-8529 for smoking cessation

July 7, 2015

Invion completes dosing in phase II trial of oral INV-102 in smoking cessation

July 1, 2015

BARDA exercises additional contract funding for AEOL-10150

July 1, 2015

NIAAA initiates trial of Horizant for alcohol use disorder

June 29, 2015

Laboratorio Farmaceutico CT patents gamma-hydroxybutyric acid prodrugs

June 22, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...